Icade SA
OTC:CDMGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
M
|
Mersana Therapeutics Inc
SWB:0M4
|
US |
Wall St Price Targets
CDMGF Price Targets Summary
Icade SA
According to Wall Street analysts, the average 1-year price target for CDMGF is 24.95 USD with a low forecast of 20.53 USD and a high forecast of 31.38 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CDMGF's stock price target?
Price Target
24.95
USD
According to Wall Street analysts, the average 1-year price target for CDMGF is 24.95 USD with a low forecast of 20.53 USD and a high forecast of 31.38 USD.
What is the Revenue forecast for Icade SA?
Projected CAGR
-39%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is -39%.
What is the Operating Income forecast for Icade SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 3%.
